For Jake Becraft, Ph.D., the future of America’s biomedical innovation isn’t just playing out in the lab but is being shaped by industrial policy. In a recent interview with Fierce Biotech, the Strand Therapeutics CEO warned that the U.S. faces a critical choice: either modernize its regulatory framework for early-stage clinical trials or risk losing the capabilities permanently.
A daily vitamin D supplement may quietly supercharge chemotherapy. In a small study, women who took low doses alongside treatment were far more likely to see their cancer vanish than those who didn’t. Since vitamin D also supports immune function—and many patients are deficient—it could be playing a bigger role than expected. Scientists say this affordable approach deserves much deeper investigati
Researchers have found an enzyme that can turn fragile drug molecules into durable ring shapes. This could help medications like Ozempic last longer and work more effectively. The process is simpler and more precise than traditional methods, even for complex drugs. It may open the door to stronger, longer-lasting treatments.
Policy that recommends offering hep B vaccine at birth only to babies perceived to be at risk will lead to increased numbers of infected infants, new studies project.
The Supreme Court seemed divided Monday over whether to block thousands of lawsuits alleging the maker of the weedkiller Roundup failed to warn people it could cause cancer.
The drugmaker Erasca said results on its experimental pill in a trial of pancreatic cancer and non-small cell lung cancer exceeded its expectations.
Kennedy broke his pledge to share a controversial contract, highlighting Democrats' frustrations with the health secretary.
The Trump administration underlines a “clear shift away from harm reduction and practices” that it says facilitates illegal drug use.
Mundipharma and CorMedix have announced a win for their antifungal drug Rezzayo at preventing invasive fungal diseases in patients receiving allogeneic hematopoietic stem cell transplants.
Years ago, Archelle Georgiou helped squash prior auths at one of America's biggest health insurers.
Eleventh-hour settlements with two of the three generic drugmakers involved could bode well for both Pfizer and its ATTR competitor BridgeBio, analysts say.
A new study reveals that internalizing stress—especially feelings of hopelessness—may significantly speed up memory decline in older Chinese Americans. Surprisingly, factors like community support didn’t show the same impact. Researchers say cultural pressures and stereotypes may cause emotional struggles to go unnoticed and untreated. The findings suggest that targeted, culturally sensitive stres
Haleon, a healthcare consumer and OTC brand company, has hired Richard Manso, a Google veteran, as its new U.S. chief marketing officer.
Compared with a 5.3% increase in Xtandi sales to $6 billion in fiscal year 2025, Astellas expects the star prostate cancer drug’s revenue to drop by 5.3% during fiscal 2026.
Already the largest biopharma company in India, generics powerhouse Sun Pharma has doubled in size with its acquisition of women’s health leader Organon. With its $11.75 billion buyout, Sun has picked up a drugmaker that matched the $6.2 billion in sales that it generated in 2025.
Scientists are making a major leap toward freezing organs for future use without damaging them. A new study reveals that one of the biggest obstacles—cracking during ultra-cold preservation—can be reduced by carefully tuning the temperature at which tissues enter a glass-like state. This breakthrough builds on recent successes in cryopreserved organ transplants and could bring the long-imagined id
Deep within the brain, scientists have uncovered a hidden “switch” that may decide whether pain fades away—or lingers for months or even years. Researchers found that a small, little-known region called the caudal granular insular cortex (CGIC) acts like a command center, telling the body to keep pain signals alive long after an injury has healed. In animal studies, shutting down this pathway not
A major new study finds that living in pesticide-heavy environments could raise cancer risk by up to 150%, even when the chemicals are considered “safe” on their own. The research suggests these mixtures may silently damage cells years before cancer appears.
Mixing up your workouts might be the real secret to a longer life. Long-term research tracking over 100,000 people for more than three decades suggests that doing a variety of physical activities—rather than just more of the same—can significantly lower the risk of death. Interestingly, the benefits don’t keep rising endlessly; they seem to level off after a certain point, hinting at a “sweet spot
An integrative medicine doctor who is the wife of the acting U.S. attorney general has been named as a member to one of the advisory councils that provides critical funding…